Beam Therapeutics Sues YolTech and Serapha Bio Over Trade Secret Theft

Key Facts

1Beam Therapeutics filed a lawsuit alleging that Chinese biotech YolTech Therapeutics and its U.S. partner Serapha Bio stole trade secrets.

2The lawsuit claims Serapha Bio, which recently merged with Boundless Bio, developed a medicine using the stolen trade secrets.

Beam Therapeutics filed a lawsuit alleging that Chinese biotech YolTech Therapeutics and its U.S. partner Serapha Bio stole trade secrets. Seeking Alpha reported that the legal action claims Serapha Bio, which recently merged with Boundless Bio, developed a medicine using the misappropriated information.

BEAM closed at $24.52 on September 29, 2026, after reaching a day high of $24.76. Meanwhile, BOLD, the stock of Boundless Bio, closed at $2.56 on the same date, trading within a range of $2.56 to $2.62.